Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 44.70
-0.10 (-0.22%)
Jun 13, 2025, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 5.76 billion as of June 12, 2025. Its market cap has decreased by -37.59% in one year.
Market Cap
5.76B
Enterprise Value
4.43B
Revenue
167.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.70
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 5.76B, an increase of 18.51%. That is a compound annual growth rate of 5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 5.76B | -15.69% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 181.96B |
| Caliway Biopharmaceuticals | 154.45B |
| Bora Pharmaceuticals Co., LTD. | 83.79B |
| Lotus Pharmaceutical | 58.50B |
| Polaris Group | 33.59B |
| Oneness Biotech | 33.29B |
| Lumosa Therapeutics | 28.19B |
| Center Laboratories | 27.49B |